Duloxetine Capsule, Delayed Release
Product Images NDC 68788-4128

This is a description for a drug called Duloxetine, a generic version of Cymbalta. Each delayed-release capsule contains 22.4mg of Duloxetine Hydrochloride equivalent to 20mg of Duloxetine. The capsules are white and blue in color and are imprinted with DLX20. The manufacturer is Ajanta Pharma Limited. The recommended storage temperature is between 15°C to 30°C. It is advised to keep the capsules out of the reach of children. The medication should only be used as prescribed by the patient, and federal law prohibits its use by anyone else. Instructions are available in Spanish. The drug is to be taken a specified number of times per day. The packaging includes information such as expiration date, lot number, and batch number.*

This data appears to be a graph showing the time from randomization to relapse in patients who received either Placebo or DULOXETINE treatment. The x-axis represents the number of days, ranging from 0 to 250, while the y-axis is labeled as the "n of Patients with Relapse." The graph may provide insights into the comparison of relapse rates between the two treatments over time.*

This text appears to be showing information related to a clinical trial or study involving a comparison between a placebo and duloxetine at doses of 60mg and 120mg taken once daily. The text also mentions percent improvement in pain from baseline.*

This text shows a graph illustrating the proportion of patients with relapse over time from randomization. The graph compares the relapse rates between patients treated with a placebo and those treated with duloxetine. The x-axis represents the time from randomization to relapse in days, while the y-axis indicates the proportion of patients experiencing relapse.*

This is a list showing the percentage of patients improved with different dosages of Duloxetine and Placebo in terms of pain improvement from baseline. The dosages are Duloxetine 60 mg BID, Duloxetine 60 mg QD, Duloxetine 20 mg QD, and Placebo. The data provides insights into how each treatment option performed in terms of pain improvement for the patients.*

This text provides a comparison of the percentage of patients improved with Duloxetine 60mg taken twice daily, once daily, and a placebo. It also mentions the percentage improvement in pain from the baseline.*

This text provides information on the percentage of patients improved in a study comparing Duloxetine 60 mg Daily with Placebo in terms of pain improvement from baseline. The data highlights different percentage levels ranging from 0 to 100 and the corresponding improvement levels at different points of evaluation, offering insights into treatment effectiveness.*

This is not-available.*

A comparison between Placebo and Duloxetine 60 mg once daily in terms of pain improvement from baseline. The text indicates a scale of 0-100 for each treatment and a percentage improvement in pain is being evaluated.*